A. Bertolini
A5104687416- COVID-19 and healthcare impacts
- COVID-19 and Mental Health
- Long-Term Effects of COVID-19
- Economic and Financial Impacts of Cancer
- Lung Cancer Diagnosis and Treatment
- HIV Research and Treatment
- Pain Management and Opioid Use
- Lung Cancer Treatments and Mutations
- Public Health in Brazil
- Respiratory Support and Mechanisms
- HIV/AIDS drug development and treatment
- Metastasis and carcinoma case studies
- Takotsubo Cardiomyopathy and Associated Phenomena
- Ovarian cancer diagnosis and treatment
- Telemedicine and Telehealth Implementation
- Cancer Diagnosis and Treatment
- Mobile Health and mHealth Applications
- Cytokine Signaling Pathways and Interactions
- Chemotherapy-induced cardiotoxicity and mitigation
- COVID-19 Clinical Research Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Genomics and Diagnostics
- Global Cancer Incidence and Screening
- Colorectal Cancer Treatments and Studies
- Child and Adolescent Health
Azienda Socio Sanitaria Territoriale della Valtellina e Alto Lario
2017-2025
Azienda Ospedaliera di Valtellina e Valchiavenna
2022
Associazione Italiana Di Oncologia Medica
2020
Ospedale di Circolo di Busto Arsizio
2016
Ospedale Valduce
2007
Lung cancer remains a leading cause of cancer-related mortality, with diagnostic delays significantly impacting patient outcomes. Despite advancements in strategies, inefficiencies persist, particularly geographically complex regions limited healthcare resources. The Fast-Track Program was developed to address these challenges lung diagnostics within the and resource-limited Valtellina region. This prospective observational study compared patients managed under pathway (May–August 2024)...
Purpose Adjuvant chemotherapy improves survival of patients with gastric cancer. Intergroup Trial Chemotherapy in Adenocarcinoma the Stomach (ITACA-S) was a phase III study comparing sequential FOLFIRI followed by docetaxel/cisplatin versus 5-fluorouracil monotherapy. The intensive regimen not superior terms disease-free (DFS) and overall (OS). Methods treatment to be started within 8 weeks from surgery. This analysis evaluates impact time surgery start (TSC) on outcomes. Results Out 1,106...
14575 Background: Cetuximab is a monoclonal antibody blocking the Epidermal Growth Factor Receptor (EGFR), that showed activity in advanced CRC. His safety and therapeutic profile clinical practice still carefully evaluating. Methods: 7 Italian Oncology Units (PoloNord Group) treated, from December 2004 to 2006, 72 patients (pts) affected by metastatic (mts) CRC, progression after two or more previous CT lines, with + CPT11 ± Fluorouracil (5FU). initial dose was 400 mg/m 2 , followed 250 as...
e18190 Background: When ASCO published Top Five List to improve cancer care in 2012, we applied the same principles build local guidelines, resulting first edition of our “Libro Blu” (Blue Book), named after a similar tool previously adopted by Swiss institution IOSI. In 2015 reform Lombardy public health, with establishment ASST-VAL, covering huge area 5 hospitals, brought further need for harmonization work; moreover, increasing appearance high cost drugs and simultaneous restrictions...